NCT06327321: Vitiligo Treatment by Targeting TYK2 Mediated Responses
- State
- Under way
- Phase
- Phase 2
- People
- 128 planned
- Started
- 5 May 2024
- Primary completion
- 5 Nov 2026
- Arms
- Drug group
- Results
- None posted
- 25 Mar 2024: Trial registered
- 5 May 2024: Trial started